(Q53297625)

13 May 2018

title

Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease. (English)

1 reference

13 May 2018

Stenotrophomonas maltophilia

main subject

cystic fibrosis

0 references

1 reference

5

1 reference

13 May 2018

Felix Ratjen

9

1 reference

13 May 2018

author name string

Valerie Waters

1

1 reference

13 May 2018

Yvonne Yau

2

1 reference

13 May 2018

Sudha Prasad

3

1 reference

13 May 2018

Annie Lu

4

1 reference

13 May 2018

Ian Crandall

6

1 reference

13 May 2018

Stephanie Tom

7

1 reference

13 May 2018

Elizabeth Tullis

8

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 October 2010

1 reference

13 May 2018

American Journal of Respiratory and Critical Care Medicine

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

13 May 2018

volume

183

1 reference

13 May 2018

issue

5

1 reference

13 May 2018

page(s)

635-640

1 reference

13 May 2018

Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1392OC

Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1392OC

Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1392OC

Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1392OC

Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1392OC

The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1392OC

Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1392OC

Characterization of flagella produced by clinical strains of Stenotrophomonas maltophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1392OC

The major extracellular protease of the nosocomial pathogen Stenotrophomonas maltophilia: characterization of the protein and molecular cloning of the gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1392OC

Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1392OC

Respiratory tract colonization with Pseudomonas aeruginosa in cystic fibrosis: correlations between anti-Pseudomonas aeruginosa antibody levels and pulmonary function

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1392OC

Immunostimulatory properties of the emerging pathogen Stenotrophomonas maltophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1392OC

Fatal pulmonary hemorrhage in patients with acute leukemia and fulminant pneumonia caused by Stenotrophomonas maltophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1392OC

Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1392OC

Cytotoxic activity of clinical Stenotrophomonas maltophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1392OC

Role of excessive inflammatory response to Stenotrophomonas maltophilia lung infection in DBA/2 mice and implications for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1392OC

Controlled study of Pseudomonas cepacia and Pseudomonas maltophilia in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1392OC

Bacterial colonisation with Xanthomonas maltophilia--a retrospective study in a cystic fibrosis patient population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1392OC

Case-control study of Stenotrophomonas maltophilia acquisition in cystic fibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1392OC

Factors affecting the incidence of Stenotrophomonas maltophilia isolation in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1392OC

The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1392OC

10.1164/RCCM.201009-1392OC

21 January 2018

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

20889901

1 reference

13 May 2018